作者:
Hultcrantz, Malin [1]
;
Anderson, Larry D., Jr. [2]
;
Anwer, Faiz [3]
;
Gasparetto, Cristina [4]
;
Kocoglu, Mehmet H. [5]
;
Lichtman, Eben I. [6]
;
Mo, Clifton [7]
;
Niesvizky, Ruben [8]
;
Lewis, Eric [9]
;
Li, Hong [10]
;
Paul, Sofia [11]
;
Petrone, Stephanie [12]
;
Kaufman, Jonathan L.
作者单位:
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[1]
Weill Cornell Med, New York, NY USA
[2]
GlaxoSmithKline, Philadelphia, PA USA
[3]
Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[4]
Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA
[5]
Duke Univ, Sch Med, Durham, NC USA
[6]
GlaxoSmithKline, Upper Providence, PA USA
[7]
GlaxoSmithKline, Res Triangle Pk, NC USA
[8]
Cleveland Clin, Taussig Canc Inst, Myeloma Program, Cleveland, OH 44106 USA
[9]
Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[10]
UT Southwestern Med Ctr, Simmons Comprehens Canc Ctr, Dallas, TX USA
[11]
Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[12]
发布时间
2021-12-22